0 followers
ORIC Pharmaceuticals is a privately held, clinical-stage oncology company focused on making cancer treatments more effective by addressing mechanisms of resistance. ORIC's lead asset, ORIC-101, is a potent and selective small-molecule antagonist of the glucocorticoid receptor. ORIC's pipeline target... Read more
Jacob Chacko
Bill & Melinda Gates Medical Research Institute
4 followers
Arine
1 follower
Kura Oncology
20 followers
Amgen
235 followers
Pfizer
526 followers
Krystal Biotech
6 followers
REVOLUTION Medicines
5 followers
Immunovant
6 followers
Empower Pharmacy
5 followers
PTM BioLab
2 followers
Stemline Therapeutics
3 followers
Explore companies